CA2186601C - Nouvelle association de betabloquant et d'un anesthesique local - Google Patents

Nouvelle association de betabloquant et d'un anesthesique local Download PDF

Info

Publication number
CA2186601C
CA2186601C CA002186601A CA2186601A CA2186601C CA 2186601 C CA2186601 C CA 2186601C CA 002186601 A CA002186601 A CA 002186601A CA 2186601 A CA2186601 A CA 2186601A CA 2186601 C CA2186601 C CA 2186601C
Authority
CA
Canada
Prior art keywords
ropivacaine
alprenolol
metoprolol
local anaesthetic
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002186601A
Other languages
English (en)
Other versions
CA2186601A1 (fr
Inventor
Arne Torsten Eek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9401174A external-priority patent/SE9401174D0/xx
Application filed by Astra AB filed Critical Astra AB
Publication of CA2186601A1 publication Critical patent/CA2186601A1/fr
Application granted granted Critical
Publication of CA2186601C publication Critical patent/CA2186601C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une nouvelle association d'un bêtabloquant, d'un de ses énantiomères et d'un anesthésique local à administrer simultanément ou séquentiellement, et procurant un excellent soulagement des douleurs. L'invention concerne également l'utilisation d'un bêtabloquant non sélectif utilisé seul, et particulièrement d'un bêtabloquant non sélectif procurant un soulagement des douleurs.
CA002186601A 1994-04-07 1995-03-24 Nouvelle association de betabloquant et d'un anesthesique local Expired - Fee Related CA2186601C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9401174-9 1994-04-07
SE9401174A SE9401174D0 (sv) 1994-04-07 1994-04-07 New combination
PCT/SE1995/000314 WO1995027511A1 (fr) 1994-04-07 1995-03-24 Nouvelle association de betabloquant et d'un anesthesique local

Publications (2)

Publication Number Publication Date
CA2186601A1 CA2186601A1 (fr) 1995-10-19
CA2186601C true CA2186601C (fr) 2007-04-03

Family

ID=37951693

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002186601A Expired - Fee Related CA2186601C (fr) 1994-04-07 1995-03-24 Nouvelle association de betabloquant et d'un anesthesique local

Country Status (1)

Country Link
CA (1) CA2186601C (fr)

Also Published As

Publication number Publication date
CA2186601A1 (fr) 1995-10-19

Similar Documents

Publication Publication Date Title
EP0820280B1 (fr) Compositions pour le traitement de la douleur
AU720407B2 (en) Optically pure (-) norcisapride for treating digestive tract disorders
US20080096872A1 (en) Composition for Treatment of Pain Specification
US5618828A (en) Methods for treating gastro-esophageal reflux disease and emesis with optically pure (-) cisapride
JP2021185175A (ja) 改善された局所麻酔のための局所麻酔薬及び血管収縮薬と組み合わせたフェノールｔｒｐｖ１アゴニストのプロドラッグ
US5629328A (en) Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (+) cisapride
KR20220132666A (ko) 지속성 국소 마취용 네오삭시톡신 조합 제형
US5856342A (en) Combination of a β-receptor blocker and a local anaesthetic
Yu et al. The development of local anesthetics and their applications beyond anesthesia
EP1728508A1 (fr) Médicament pour la prévention ou le traitement de la miction fréqente ou de l'incontinence urinaire
JP4933265B2 (ja) フルピルチン及びトラマドールの組み合わせ
CA2186601C (fr) Nouvelle association de betabloquant et d'un anesthesique local
JPH11511465A (ja) ハロアルキルアミン及び局所麻酔薬製剤並びに反射性交感神経性ジストロフィー（ｒｓｄ）の治療法
US5908847A (en) Combination of a β-receptor blocker and an opioid
Minto et al. New opioid analgesics: an update
Goudas Clonidine
KRAEMER III Local Anesthetics and Adjuvant Analgesics
Varner et al. Chloroephedrine: contaminant of methamphetamine synthesis with cardiovascular activity
AU2003220743B2 (en) Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
Mathews Efficiency of Buprinorphine in 2% Lignocain 1: 80,000 Combination for Post-Operative Anlgesia Afterof Impacted Mandibular Third Molar-A Prospective Clinical Study
JPWO2005089742A1 (ja) 頻尿または尿失禁の予防または治療用医薬
JPH0827029A (ja) ５ｈｔ１ 作動薬の新規医薬用途

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed